SPRB
Spruce Biosciences, Inc.
45.70$
+2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.4% | 98.3% | 98.1% | 97.9% | 97.7% | 97.8% | 96.6% | 96.0% | 94.8% | 98.3% | 98.0% | 98.3% | |
| 87.4% | 92.7% | 92.7% | 92.3% | 92.2% | 85.7% | 80.9% | 75.1% | 69.7% | 92.2% | 96.3% | 93.6% | |
| 95.6% | 92.7% | 92.7% | 92.3% | 92.2% | – | 80.9% | 75.1% | 69.7% | 92.2% | 96.3% | 93.6% | |
| 24.4% | 26.4% | 23.9% | 21.7% | 20.7% | 36.2% | 51.6% | 39.6% | 64.8% | 19.8% | 38.3% | 18.6% | |
| 21.4% | 23.5% | 21.0% | 18.9% | 18.2% | 33.7% | 49.5% | 36.9% | 61.6% | 19.0% | 21.0% | 10.7% | |
| 1.7% | 1.8% | 2.1% | 2.5% | 2.9% | – | 5.2% | 5.7% | 5.5% | 0.6% | 2.4% | 2.8% | |
| 2.8% | 3.2% | 2.2% | 0.9% | 2.8% | 2.9% | 5.9% | 3.7% | 9.1% | 1.8% | 4.8% | 1.2% | |
| 1.9% | 1.7% | 1.5% | 1.2% | 0.8% | 0.3% | – | – | – | – | 9.7% | 4.5% | |
| 75.6% | 73.6% | 76.1% | 78.3% | 79.3% | 63.8% | 48.4% | 60.4% | 35.2% | 80.2% | 61.7% | 81.4% | |
| -165.8% | -189.7% | -238.6% | -288.7% | -348.2% | -553.6% | -835.1% | -1,220.8% | -1,793.2% | -545.5% | -536.8% | -308.9% | |
| 0.5% | 0.5% | 0.6% | 0.7% | 0.8% | 1.2% | 1.8% | 2.8% | 3.7% | 1.4% | 2.4% | 2.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.